Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015
Summary
GlobalDatas clinical trial report, Autoimmune Hepatitis Global Clinical Trials Review, H1, 2015 provides data on the Autoimmune Hepatitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Autoimmune Hepatitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Autoimmune Hepatitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Autoimmune Hepatitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Autoimmune Hepatitis 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Autoimmune Hepatitis Therapeutics Clinical Trials 29
Prominent Drugs 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Veloxis Pharmaceuticals A/S 31
Clinical Trial Overview of Veloxis Pharmaceuticals A/S 31
Iltoo Pharma 32
Clinical Trial Overview of Iltoo Pharma 32
Dr. Falk Pharma GmbH 33
Clinical Trial Overview of Dr. Falk Pharma GmbH 33
BioIncept, LLC 34
Clinical Trial Overview of BioIncept, LLC 34
Alfact Innovation 35
Clinical Trial Overview of Alfact Innovation 35
Clinical Trial Overview of Top Institutes / Government 36
Beijing 302 Hospital 36
Clinical Trial Overview of Beijing 302 Hospital 36
Juntendo University School of Medicine 37
Clinical Trial Overview of Juntendo University School of Medicine 37
Mayo Clinic 38
Clinical Trial Overview of Mayo Clinic 38
Rigshospitalet 39
Clinical Trial Overview of Rigshospitalet 39
Tehran University of Medical Sciences 40
Clinical Trial Overview of Tehran University of Medical Sciences 40
The National Institute of Allergy and Infectious Diseases 41
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 41
University of Sao Paulo General Hospital 42
Clinical Trial Overview of University of Sao Paulo General Hospital 42
Five Key Clinical Profiles 43
Appendix 59
Abbreviations 59
Definitions 59
Research Methodology 60
Secondary Research 60
About GlobalData 61
Contact Us 61
Disclaimer 61
Source 61
List Of Tables
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region, 2015* 7
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Autoimmune Hepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Autoimmune Hepatitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Autoimmune Hepatitis Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 27
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Veloxis Pharmaceuticals A/S, 2015* 31
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Iltoo Pharma, 2015* 32
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2015* 33
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by BioIncept, LLC, 2015* 34
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Alfact Innovation, 2015* 35
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beijing 302 Hospital, 2015* 36
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Juntendo University School of Medicine, 2015* 37
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 38
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015* 39
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 40
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 41
Autoimmune Hepatitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2015* 42
List Of Figures
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Autoimmune Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Autoimmune Hepatitis Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Autoimmune Hepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Autoimmune Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Autoimmune Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Autoimmune Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Autoimmune Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 26
Autoimmune Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 27
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 28
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 29
Autoimmune Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 30
GlobalData Methodology 60
